Asarfi Hospital Limited · BSE:ASARFI

Asarfi Hospital — Q1 FY27 Earnings Presentation

25 slides from Asarfi Hospital's earnings presentation, Aug 7, 2026

  1. Slide 1: Submission of Investor Presentation to BSE

    असफ हॉ ीटल सबके िलए ा AHL/AO/2026/1340 Date: 07 August 2026 To The Listing Department BSE Limited 25th Floor, Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001 Sub: Submission of Investor Presentation for the Quarter Ended 30 June 2026. Ref: Scrip Code: 543943 Dear Sir/Madam, Pursuant to Regul

  2. Slide 2: Investor Presentation Q1'FY27

    20+ Years Trust | Quality | Care Leading Healthcare Provider in Eastern India Investor Presentation Q1’FY27

  3. Slide 3: Disclaimer

    Disclaimer Certain matters discussed in this presentation may contain statements regarding the company's market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements do not guarantee future performance and are subject to

  4. Slide 4: Q1'FY27 Highlights

    Q1’FY27 Highlights 3

  5. Slide 5: Quarterly Snapshot – Q1'FY27 (YoY)

    Quarterly Snapshot – Q1’FY27 (YoY) Q1’FY27 Revenue Q1’FY27 EBITDA Q1’FY27 EBITDA Margin Q1’FY27 PAT Rs Rs 47.5 130 Cr (+10% (33.2%YoY) YoY) Rs 9.5 130Cr Cr(35.3% (+10% YoY) Rs 13019.9% Cr (+10% YoY) 4.3 Cr Rs 130 Cr(36.7% (+10% YoY) VsVs RsRs 120CrCrininQ1’FY26 35.7 FY25 Vs Rs Vs Rs 7120 Cr Q1’FY26

  6. Slide 6: Quarterly Profit and Loss Summary

    Quarterly Profit and Loss Summary Standalone (₹ in Lakhs) Consolidated (₹ in Lakhs) Particulars Q1’FY26* Q4'FY26 Q1’FY27 QoQ % YoY% Particulars Q1’FY26* Q4'FY26 Q1’FY27 QoQ % YoY% Revenue from operations 3,566 4,503 4,734 5.1% 32.8% Revenue from operations 3,568 4,524 4,753 5.1% 33.2% Material costs

  7. Slide 7: Quarterly Highlights – Q1'FY27

    Quarterly Highlights – Q1’FY27 Financials (Standalone): IPD-OPD Revenues (₹ in lakhs): Revenue Growth YoY EBITDA Margin 3,935 32.8% 19.9% 2,997 to ₹47 Cr in Q1’FY27 in Q1’FY27 (vs ₹35 Cr in Q1’FY26) (vs 19.7% in Q1’FY26) 31% YoY Growth in IPD Revenues 753 522 EBIT Margin PAT Margin 14.5% 9.0% Q1'FY2

  8. Slide 8: Key Financial Parameters Over The Period - Standalone

    Key Financial Parameters Over The Period - Standalone Revenue (₹ in Lakhs) EBITDA (₹ in Lakhs) and Margin % 12,000 10,000 +33% 1,200 19.7% 19.9% 17.4% 8,000 1,000 +5% 800 6,000 600 4,000 400 3,566 4,503 4,734 2,000 200 703 786 942 0 0 Q1'FY26 Q4'FY26 Q1'FY27 Q1'FY26 Q4'FY26 Q1'FY27 EBIT (₹ in Lakhs)

  9. Slide 9: Key Financial Parameters Over The Period - Consolidated

    Key Financial Parameters Over The Period - Consolidated Revenue (₹ in Lakhs) EBITDA (₹ in Lakhs) and Margin % 12,000 10,000 +33% 1,200 19.9% 19.6% 17.1% 8,000 1,000 +5% 800 6,000 600 4,000 400 3,568 4,524 4,753 2,000 200 699 772 946 0 0 Q1'FY26 Q4'FY26 Q1'FY27 Q1'FY26 Q4'FY26 Q1'FY27 EBIT (₹ in Lakh

  10. Slide 10: Revenue Mix – Q1'FY27 vs Q1'FY26 (Super-Specialty)

    Revenue Mix – Q1’FY27 vs Q1’FY26 Super-Specialty Hospital Unit Q1'FY27 YoY Revenue Growth % by Specialty Cardiology Cardiology 2.9% 16% General Medicine General Medicine 23.7% 23% Neurosciences 28.5% Neurosciences 5% General Surgery Q1’FY27 General Surgery 13.9% 7% Total Revenue Paediatrics and Neon

  11. Slide 11: Revenue Mix – Q1'FY27 vs Q1'FY26 (Cancer Hospital)

    Revenue Mix – Q1’FY27 vs Q1’FY26 Cancer Hospital Unit Q1'FY27 YoY Revenue Growth % by Specialty Medical Oncology 36% 23% Medical Oncology -53% Surgical Oncology Q1’FY27 Surgical Oncology Total Revenue 53% ₹ 9.8 Cr. Radiation Oncology Radiation Oncology 45% 18% Others* 6% Others* 185% 12% Revenue Con

  12. Slide 12: IPD-OPD Highlights (Both Hospital Units)

    IPD-OPD Highlights (Both Hospital Units) IPD-OPD Volumes IPD-OPD Revenues (₹ in Lakhs) IPD +7% IPD +31% OPD +12% OPD +44% IPD +8% IPD +5% OPD +8% OPD +6% 40,000 36,958 5,000 32,986 34,160 3,751 3,935 30,000 4,000 2,997 3,000 20,000 2,000 10,000 4,236 1,000 522 708 753 3,947 3,909 0 0 Q1'FY26 Q4'FY26

  13. Slide 13: Super-Specialty Hospital Unit

    Unit-wise ARPOB, Bed Capacity and Occupancy % ARPOB Super-Specialty Hospital Unit Bed Capacity and Occupancy %* +21% Reasons for decrease in ARPOB (Q1’FY27 vs Q4’FY26) in Super-Specialty Unit: 64% 56% 59% -10% 300  Addition of 20 critical care beds, 30,000 200 resulting in temporary ARPOB 20,000 di

  14. Slide 14: Surgery Count

    Surgery Count Surgery Count ~28% (Total Surgery Count) Total: 1,980 2000 Total: 1,608 137 Total: 1,549 1800 111 146 1600 79 62 54 55 82 99 1400 56 73 139 68 64 88 1200 156 248 158 143 1000 154 191 159 800 415 343 460 600 400 200 474 492 431 0 Q1'FY26 Q4'FY26 Q1'FY27 Cardiology Gastroenterology Gener

  15. Slide 15: Quarterly Updates

    Quarterly Updates 14

  16. Slide 16: Key Quarterly Updates

    Key Quarterly Updates • Asarfi Cancer Institute hosted the two-day Cancer Conclave 2026 (27–28 June 2026) at Dhanbad, themed "Prevention to Cure," bringing together 200+ oncologists from AIIMS Deoghar, HCG Ranchi, CNCI Kolkata, and other leading institutions to discuss early detection and advances i

  17. Slide 17: Asarfi Hospital At A Glance

    Asarfi Hospital At A Glance * Actual photo of Asarfi Hospital. 16

  18. Slide 18: Asarfi Hospital: Leading Healthcare Player In Jharkhand

    Asarfi Hospital: Leading Healthcare Player In Jharkhand Healthcare Excellence Since 2005 20+ Years of Experience  Serving Dhanbad and neighboring areas for 20+ years with affordable, best-in-class healthcare facilities. Operating two hospitals with 350 total beds across Super- Specialty and Cancer

  19. Slide 19: Journey Over The Years

    Journey Over The Years 2005 2008 2016 2017 2022 2023 2024 2025 2026 Incorporation IPD Dept Expansion Expansion Cancer hospital IPO Cancer hospital Strategic Tech Phase 1 Phase 2 construction operationalised partnership Upgradation 2005-2009: Foundation 2016-2024: Expansion and IPO 2025-2026 and Beyo

  20. Slide 20: Our Departments

    Our Departments Paediatrics & Obstetrics & Cardiology Neurosciences General medicine General Surgery Neonatology Gynaecology Gastroenterology Orthopaedics Burn & Plastic Surgery Oncology Nephrology Urology Ophthalmology ENT Day Care services Dental Sciences Physiotherapy Emergency Nutrition & Dietet

  21. Slide 21: Backed By Cutting-Edge Infrastructure and Facilities

    Backed By Cutting-Edge Infrastructure and Facilities Asarfi Hospital, Dhanbad 285 Beds | ₹23,498 ARPOB | 59% Occupancy | ALOS 4.2 Days  Established in 2005  Specialty in Cardiology, General Medicine and Philips Azurion 5 M12 Neurology (~52% Revenues) Image-Guided Therapy System  Facilities: Full-

  22. Slide 22: Delivering Consistent Shareholder Returns

    Delivering Consistent Shareholder Returns Stock Info Share Price History Asarfi Hospital Limited is planning to migrate BSE Scrip Code SME: 543943 from BSE SME to Main Board, subject to Shares Outstanding 1,96,77,300 regulatory requirements and approvals. 52-Week Range (INR) 117 - 257 300 Free Float

  23. Slide 23: Competitive Strengths

    Competitive Strengths Concentric Impact Regional Advantage Technology Leadership 30 Lakh+  Eastern India’s healthcare  Equipped with Jharkhand’s first Population Served market offers a compelling and most advanced Linear Eastern India growth opportunity, Accelerator radiation machine- underpinned

  24. Slide 24: Leadership Team

    Leadership Team Harendra Singh Udai Pratap Singh Sukanti Kumar Das Promoter & CFO Promoter & MD Non-Executive Director • A visionary entrepreneur inspired by • Started his career in 2017, he is a • Renowned Consultant Gynaecologist the Company’s Purpose—Health for All. process and system driven pers

  25. Slide 25: Thank You

    Thank You Contact Details: Mr. Udai Pratap Singh Managing Director (MD) Contact No. - 9608833708 Email Id - cs@asarfihospital.com ASARFI HOSPITAL LIMITED | Baramuri, B Polytechnic, Dhanbad, Jharkhand 828130 | CIN - L85110JH2005PLC011673 | cs@asarfihospital.com | www.asarfi.in 24

Asarfi Hospital — Q1 FY27 Earnings Presentation on 6ix